Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:diabetes
|
gptkbp:administered_before |
Meals
|
gptkbp:administered_by |
Subcutaneous injection
Before breakfast Before dinner Before lunch Intravenously in emergencies |
gptkbp:affects |
Blood sugar levels
|
gptkbp:can_be_combined_with |
Long-acting insulin
|
gptkbp:can_be_used_in |
Pregnant women under supervision
|
gptkbp:can_be_used_with |
Insulin pumps
Carbohydrate counting |
gptkbp:can_cause |
Allergic reactions
|
gptkbp:developed_by |
1920s
|
gptkbp:duration |
3 to 6 hours
|
gptkbp:form |
Pens
Vials |
gptkbp:highest_point |
2 to 3 hours
|
https://www.w3.org/2000/01/rdf-schema#label |
Short-acting insulin
|
gptkbp:is |
A cure for diabetes
A long-acting insulin A rapid-acting insulin |
gptkbp:is_associated_with |
Improved quality of life
|
gptkbp:is_available_in |
Pre-filled syringes
Insulin pens U-100 concentration U-500 concentration |
gptkbp:is_considered |
Essential medicine by WHO
|
gptkbp:is_effective_against |
Insulin resistance
|
gptkbp:is_linked_to |
Reduced complications of diabetes
|
gptkbp:is_more_effective_in |
Type 2 diabetes
|
gptkbp:is_part_of |
Insulin therapy
Combination therapy Diabetes education programs Diabetes treatment plan |
gptkbp:is_recommended_for |
Newly diagnosed diabetes patients
|
gptkbp:is_standardized_by |
Regular insulin
|
gptkbp:is_subject_to |
Prescription regulations
|
gptkbp:is_used_in |
Emergency situations
|
gptkbp:is_used_to |
Control postprandial blood sugar
Manage hyperglycemia Prevent ketoacidosis |
gptkbp:measures |
Units
|
gptkbp:premiered_on |
30 minutes
|
gptkbp:produced_by |
Pancreas
|
gptkbp:requires |
Dietary management
Blood glucose monitoring |
gptkbp:shelf_life |
28 days after opening
|
gptkbp:side_effect |
Weight gain
Hypoglycemia |
gptkbp:storage |
Refrigeration
|
gptkbp:suitable_for |
Non-diabetic individuals
Type 1 diabetes without basal insulin |
gptkbp:used_for |
Diabetes management
|
gptkbp:bfsParent |
gptkb:diabetes
|
gptkbp:bfsLayer |
4
|